{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:31:57Z","timestamp":1791117117160,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.humpath.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,4,19]],"date-time":"2012-04-19T03:08:39Z","timestamp":1334804919000},"page":"1828-1838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation"],"prefix":"10.1016","volume":"43","author":[{"given":"Daniela","family":"Hoehn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2012.01.003_bb0005","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"185","article-title":"Splenic B-cell marginal zone lymphoma","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.humpath.2012.01.003_bb0010","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"191","article-title":"Splenic B-cell lymphoma\/leukaemia, unclassifiable","author":"Piris","year":"2008"},{"key":"10.1016\/j.humpath.2012.01.003_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging, and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2012.01.003_bb0020","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1309\/HRHQFBFTR8B4LXT4","article-title":"Bone marrow involvement by marginal zone B-cell lymphomas of different types","volume":"129","author":"Inamdar","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0025","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chacon","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.01.003_bb0030","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V84.11.3828.bloodjournal84113828","article-title":"The histopathology of splenic lymphoma with villous lymphocytes","volume":"84","author":"Isaacson","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.01.003_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcp\/105.3.277","article-title":"Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases","volume":"105","author":"Wu","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0040","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0046-8177(99)90031-X","article-title":"Splenic marginal zone lymphoma with increased number of blasts: an aggressive variant?","volume":"30","author":"Lloret","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1974.tb06769.x","article-title":"Prolymphocytic leukemia","volume":"27","author":"Galton","year":"1974","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2141.1979.tb03676.x","article-title":"\u201cProlymphocytoid\u201d transformation of chronic lymphocytic leukemia","volume":"41","author":"Enno","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1309\/PPK0-TJUK-1UAR-3194","article-title":"Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma","volume":"115","author":"Schlette","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1309\/4LTE-JHNC-C8RC-FGWL","article-title":"Nucleolated variant of mantle cell lymphoma with leukemic manifestations mimicking prolymphocytic leukemia","volume":"117","author":"Wong","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0065","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"183","article-title":"B-cell prolymphocytic leukaemia","author":"Campo","year":"2008"},{"key":"10.1016\/j.humpath.2012.01.003_bb0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1309\/5DGB59KQA527PD47","article-title":"Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations","volume":"122","author":"Oyarzo","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0075","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/S0046-8177(03)00412-X","article-title":"Cytogenetic findings in blastoid mantle cell lymphoma","volume":"34","author":"Khoury","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0080","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3324\/haematol.2009.011049","article-title":"CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases","volume":"95","author":"Baseggio","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2012.01.003_bb0085","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/path.2665","article-title":"Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis","volume":"220","author":"Watkins","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0095","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.01.003_bb0100","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2008.07176.x","article-title":"Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32, and 7q36.2 that include the protection of telomere 1 (POT1 and sonic hedgehog (SHH) genes","volume":"142","author":"Vega","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1532\/IJH97.05017","article-title":"Blastic transformation after splenectomy in a patient with nonvillous splenic marginal zone lymphoma with p53 overexpression: a case report","volume":"81","author":"Kakinoki","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.humpath.2012.01.003_bb0110","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic entity?","volume":"111","author":"Traverse-Glehen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2012.01.003_bb0115","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1038\/leu.2009.137","article-title":"B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures","volume":"23","author":"Del Giudice","year":"2009","journal-title":"Leukemia"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712000081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817712000081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:33:28Z","timestamp":1758645208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817712000081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0046817712000081"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2012.01.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2012.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}